Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000925
Filing Date
2025-03-27
Accepted
2025-03-27 16:05:50
Documents
119
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 2088614
2 ex10-45.htm EX-10.45 20912
3 ex19.htm EX-19 105662
4 ex21-1.htm EX-21.1 7352
5 ex23-1.htm EX-23.1 5537
6 ex23-2.htm EX-23.2 4572
7 ex31-1.htm EX-31.1 17023
8 ex31-2.htm EX-31.2 17004
9 ex32-1.htm EX-32.1 7614
10 ex32-2.htm EX-32.2 7353
11 ex10-45_001.jpg GRAPHIC 14023
12 ex19_001.jpg GRAPHIC 16310
  Complete submission text file 0001641172-25-000925.txt   11743210

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE hrow-20241231.xsd EX-101.SCH 79545
14 XBRL CALCULATION FILE hrow-20241231_cal.xml EX-101.CAL 107157
15 XBRL DEFINITION FILE hrow-20241231_def.xml EX-101.DEF 408929
16 XBRL LABEL FILE hrow-20241231_lab.xml EX-101.LAB 706662
17 XBRL PRESENTATION FILE hrow-20241231_pre.xml EX-101.PRE 588408
122 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1901281
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 25779285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)